medmeters.
FUNCTIONAL ASSESSMENTS · 2026

Can computer vision score Sit-to-Stand, TUG and SPPB?

Automated scoring of clinical mobility tests is already supported by patient-level validation research.

Clinician-guided sit-to-stand assessment
MedMeters literature review prepared 31 October 2026. The year in the article heading refers to the original study publication, not an earlier MedMeters posting date.
228 adultswith chronic conditions · findings from external research

Clinical question

Can a mobile vision system produce scores that agree with a clinical assessor during routine mobility tests?

Study design

Researchers enrolled 228 adults with at least one chronic medical condition. A certified exercise physiologist and a markerless motion-capture application scored 30-second Sit-to-Stand, Timed Up and Go and the component tasks of the Short Physical Performance Battery at the same time. The app used a LiDAR-enabled iPad.

What the researchers found

Agreement was good to excellent across tested tasks: ICCs ranged from 0.812 for tandem standing to 0.995 for five-times Sit-to-Stand. Overall SPPB score showed weighted kappa 0.808; technology-related data loss was 3.1%.

Why this matters for MedMeters

This is direct feasibility evidence for the first MedMeters Mobility modules. It supports the idea of automated timing and scoring within defined clinical protocols rather than a generic movement score.

What this does not prove

The app, hardware and study population were not MedMeters. It used LiDAR hardware, supervised testing and its own algorithms; results cannot be transferred to ordinary single-camera RGB video or unsupervised home testing.

Original peer-reviewed publication

Validation of a markerless motion capture app for automated scoring of sit-to-stand, timed up and go, and short physical performance battery tests in adults with chronic disease
Bertrand et al. · PLOS Digital Health · 2026
DOI: 10.1371/journal.pdig.0001172

External scientific evidence summary. Not medical advice. MedMeters is a concept under development and has not been evaluated in these studies. Clinical claims, validation and regulatory status must be established separately.